Olin Set to Expand Bleach Distribution With K2 Partnership

01.07.25 16:30 Uhr

Werte in diesem Artikel
Aktien

17,70 EUR -0,70 EUR -3,80%

Indizes

PKT PKT

Olin Corporation OLN announced to strengthen its bleach distribution network across California and the Western United States in collaboration with K2. The partnership aims to improve supply chain continuity, increase geographical expanse and better its service responsiveness.In a broader sense, the availability of bleach in this region will reduce the amount of railcar chlorine transported into the region. It is expected that more localized bleach will be produced and distributed, supporting the goals of safety, environmental responsibility, and supply chain resilience.Olin’s market expertise and K2’s strength in regional production will ensure a safe and reliable supply to maintain public health. They will together set higher standards in the bleach production and distribution industry, ensuring optimum customer satisfaction.For Q2 2025, OLN expects its Chemicals segment’s performance to remain steady despite higher costs from a delayed maintenance turnaround. The Winchester unit is projected to see improved results driven by seasonal demand and stronger military sales. Adjusted EBITDA is forecasted between $170 million and $210 million. Full-year 2025 capital expenditure is expected to range from $200 million to $220 million.OLN stock has slumped 55.3% over the past year against the industry’s 18.6% decline.Image Source: Zacks Investment ResearchOLN’s Zacks Rank & Key PicksOLN currently carries a Zacks Rank #3 (Hold).Some better-ranked stocks in the Basic Materials space are Newmont Corporation NEM, Akzo Nobel N.V. AKZOY and CF Industries CF. While NEM currently sports a Zacks Rank #1 (Strong Buy), AKZOY and CF carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for NEM’s current-year earnings is pegged at $4.32 per share, indicating a 24.14% year-over-year increase.Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with an average surprise of 32.41%. NEM’s shares have gained 42.7% in the past year.The Zacks Consensus Estimate for Akzo Nobel’s current-year earnings is pegged at $1.69 per share, implying a 20.71% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters while missing once.The Zacks Consensus Estimate for CF’s 2025 earnings is pegged at $6.83 per share, indicating a rise of 1.34% from year-ago levels. The company’s earnings beat the consensus estimate in each of the trailing four quarters. Its shares have gained 33% in the past year.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Newmont Corporation (NEM): Free Stock Analysis Report CF Industries Holdings, Inc. (CF): Free Stock Analysis Report Akzo Nobel NV (AKZOY): Free Stock Analysis Report Olin Corporation (OLN): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Olin und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Olin

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Olin

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Olin Corp.

Wer­bung

Analysen zu Olin Corp.

DatumRatingAnalyst
06.05.2019Olin OutperformCowen and Company, LLC
06.02.2019Olin OutperformCowen and Company, LLC
11.12.2018Olin BuyStifel, Nicolaus & Co., Inc.
28.08.2018Olin BuyStandpoint Research
06.08.2018Olin OutperformCowen and Company, LLC
DatumRatingAnalyst
06.05.2019Olin OutperformCowen and Company, LLC
06.02.2019Olin OutperformCowen and Company, LLC
11.12.2018Olin BuyStifel, Nicolaus & Co., Inc.
28.08.2018Olin BuyStandpoint Research
06.08.2018Olin OutperformCowen and Company, LLC
DatumRatingAnalyst
02.02.2017Olin NeutralMonness, Crespi, Hardt & Co.
03.11.2015Olin NeutralUBS AG
21.09.2015Olin Market PerformCowen and Company, LLC
08.09.2015Olin Sector PerformRBC Capital Markets
31.03.2015Olin Sector PerformRBC Capital Markets
DatumRatingAnalyst
24.03.2015Olin SellUBS AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Olin Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen